Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2718) 2718
Publication (487) 487
Newsletter (86) 86
Book Review (35) 35
Magazine Article (11) 11
Book Chapter (10) 10
Conference Proceeding (3) 3
Dissertation (2) 2
Book / eBook (1) 1
Data Set (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
linezolid (2371) 2371
humans (1632) 1632
pharmacology & pharmacy (1377) 1377
index medicus (1184) 1184
microbiology (1174) 1174
anti-bacterial agents - pharmacology (1048) 1048
oxazolidinones - pharmacology (949) 949
microbial sensitivity tests (936) 936
acetamides - pharmacology (895) 895
infectious diseases (806) 806
vancomycin (651) 651
male (607) 607
female (555) 555
oxazolidinones - therapeutic use (491) 491
acetamides - therapeutic use (487) 487
anti-bacterial agents - therapeutic use (477) 477
antibiotics (406) 406
infections (400) 400
middle aged (390) 390
staphylococcus aureus - drug effects (380) 380
staphylococcal infections - microbiology (352) 352
adult (344) 344
staphylococcal infections - drug therapy (336) 336
aged (330) 330
animals (322) 322
oxazolidinones (304) 304
drug resistance, bacterial (303) 303
biochemical phenomena, metabolism, and nutrition (302) 302
vancomycin - pharmacology (293) 293
staphylococcus aureus (280) 280
bacteria (266) 266
daptomycin (262) 262
methicillin-resistant staphylococcus aureus - drug effects (253) 253
pharmacokinetics (252) 252
gram-positive bacterial infections - drug therapy (249) 249
drug resistance (248) 248
drug resistance in microorganisms (244) 244
susceptibility (243) 243
bacterial infections and mycoses (242) 242
anti-infective agents - pharmacology (240) 240
oxazolidinones - administration & dosage (233) 233
acetamides - administration & dosage (230) 230
staphylococcus-aureus (228) 228
gram-positive bacterial infections - microbiology (227) 227
linezolid - pharmacology (219) 219
treatment outcome (216) 216
oxazolidinones - pharmacokinetics (210) 210
oxazolidinones - adverse effects (207) 207
acetamides - pharmacokinetics (204) 204
resistant staphylococcus-aureus (199) 199
acetamides - adverse effects (197) 197
anti-bacterial agents - administration & dosage (197) 197
resistance (194) 194
research (191) 191
health aspects (188) 188
antibacterial agents (187) 187
antimicrobial agents (186) 186
hospitals (180) 180
anti-bacterial agents - pharmacokinetics (174) 174
infection (171) 171
methicillin resistance (168) 168
oxazolidinone (165) 165
vancomycin - therapeutic use (163) 163
infectious disease (162) 162
gram-positive bacteria - drug effects (161) 161
anti-infective agents - therapeutic use (158) 158
aged, 80 and over (154) 154
anti-bacterial agents - adverse effects (154) 154
drug resistance, multiple, bacterial (154) 154
mrsa (154) 154
enterococcus faecium - drug effects (149) 149
daptomycin - pharmacology (146) 146
drug therapy (146) 146
linezolid resistance (146) 146
pneumonia (138) 138
staphylococcus aureus infections (138) 138
analysis (137) 137
staphylococcus infections (137) 137
risk factors (136) 136
therapy (136) 136
mutation (135) 135
pharmacology (135) 135
vancomycin resistance (134) 134
rna, ribosomal, 23s - genetics (129) 129
in-vitro (128) 128
chemistry, medicinal (126) 126
oxazolidinones - chemistry (125) 125
retrospective studies (125) 125
internal medicine (123) 123
dosage and administration (122) 122
mice (120) 120
drugs (119) 119
in-vitro activity (118) 118
efficacy (117) 117
methicillin-resistant staphylococcus aureus (117) 117
care and treatment (116) 116
enterococcus - drug effects (116) 116
united-states (116) 116
drug resistance, bacterial - genetics (115) 115
enterococcus faecalis - drug effects (115) 115
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2695) 2695
Spanish (52) 52
Japanese (23) 23
Turkish (14) 14
French (8) 8
German (8) 8
Russian (8) 8
Chinese (6) 6
Italian (3) 3
Polish (2) 2
Swedish (2) 2
Arabic (1) 1
Danish (1) 1
Dutch (1) 1
Portuguese (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Activity of Ceftaroline and Epidemiologic Trends in Staphylococcus aureus Isolates Collected from 43 Medical Centers in the United States in 2009
by Sandra S. Richter and Kristopher P. Heilmann and Cassie L. Dohrn and Fathollah Riahi and Andrew J. Costello and Jennifer S. Kroeger and Donald Biek and Ian A. Critchley and Daniel J. Diekema and Gary V. Doern
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 09/2011, Volume 55, Issue 9, pp. 4154 - 4160
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit... 
Leukocidins - genetics | Linezolid | Staphylococcus aureus - genetics | Levofloxacin | Erythromycin - pharmacology | United States | Methicillin-Resistant Staphylococcus aureus - drug effects | Oxacillin - pharmacology | Tetracycline - pharmacology | Acetamides - pharmacology | Mupirocin - pharmacology | Electrophoresis, Gel, Pulsed-Field | Clindamycin - pharmacology | Microbial Sensitivity Tests | Daptomycin - pharmacology | Ofloxacin - pharmacology | Trimethoprim, Sulfamethoxazole Drug Combination - pharmacology | Oxazolidinones - pharmacology | Vancomycin - pharmacology | Exotoxins - genetics | Polymerase Chain Reaction | Bacterial Toxins - genetics | Staphylococcus aureus - drug effects | Cephalosporins - pharmacology | INFECTIONS | STREPTOCOCCUS-PNEUMONIAE | INVASIVE DISEASE | PENICILLIN-BINDING PROTEINS | RESISTANCE | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | SKIN | IDENTIFICATION | EMERGENCE | CEPHALOSPORIN | PATHOGENS | Susceptibility
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Influence on Mitochondria and Cytotoxicity of Different Antibiotics Administered in High Concentrations on Primary Human Osteoblasts and Cell Lines
by N. Duewelhenke and O. Krut and P. Eysel
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 01/2007, Volume 51, Issue 1, pp. 54 - 63
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit... 
TRABECULAR BONE | IN-VITRO | DNA | MACROLIDE | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | RIFAMPICIN | ROXITHROMYCIN | AZITHROMYCIN | PROTEIN-SYNTHESIS | MAMMALIAN-CELLS | CIPROFLOXACIN | Linezolid | Humans | Acetamides - pharmacology | Tetracyclines - pharmacology | Glycolysis - drug effects | Antimycin A - pharmacology | Clindamycin - pharmacology | Dose-Response Relationship, Drug | Time Factors | Chloramphenicol - pharmacology | Rotenone - pharmacology | Macrolides - pharmacology | Osteoblasts - cytology | Cell Survival - drug effects | Lactic Acid - metabolism | Osteoblasts - drug effects | Cells, Cultured | Mitochondria - drug effects | Oxazolidinones - pharmacology | Fluoroquinolones - pharmacology | Cell Line, Tumor | Anti-Bacterial Agents - pharmacology | Cell Proliferation - drug effects | HeLa Cells | Aminoglycosides - pharmacology | Pharmacology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text High-Level Vancomycin-Resistant Staphylococcus aureus Isolates Associated with a Polymicrobial Biofilm
by Linda M. Weigel and Rodney M. Donlan and Dong Hyeon Shin and Bette Jensen and Nancye C. Clark and Linda K. McDougal and Wenming Zhu and Kimberlee A. Musser and Jill Thompson and Donna Kohlerschmidt and Nellie Dumas and Ronald J. Limberger and Jean B. Patel
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 01/2007, Volume 51, Issue 1, pp. 231 - 238
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit... 
INFECTIONS | BACTERIA | UNITED-STATES HOSPITALS | GENE TET(S) | FAECIUM | COMMUNITY | DISEASE | ENTEROCOCCUS-FAECALIS | DETERMINANT | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | IDENTIFICATION | Linezolid | Enterococcus faecium - drug effects | Enterococcus faecalis - drug effects | Vancomycin Resistance - drug effects | Humans | Middle Aged | Acetamides - pharmacology | Tetracyclines - pharmacology | Microbial Sensitivity Tests | Morganella morganii - drug effects | Vancomycin - pharmacology | Chloramphenicol - pharmacology | Macrolides - pharmacology | Catheters, Indwelling - microbiology | Female | Penicillins - pharmacology | Vancomycin Resistance - genetics | Biofilms - drug effects | Staphylococcus aureus - genetics | Pseudomonas aeruginosa - drug effects | Trimethoprim, Sulfamethoxazole Drug Combination - pharmacology | Oxazolidinones - pharmacology | Urinary Catheterization | Fluoroquinolones - pharmacology | Rifampin - pharmacology | Aminoglycosides - pharmacology | Drug Resistance, Multiple, Bacterial - genetics | Staphylococcus aureus - drug effects | Micrococcus - drug effects | Mechanisms of Resistance
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text TXA709, an FtsZ-targeting benzamide prodrug with improved pharmacokinetics and enhanced in vivo efficacy against methicillin-resistant Staphylococcus aureus
by Kaul, Malvika and Mark, Lilly and Zhang, Yongzheng and Parhi, Ajit K and Lyu, Yi Lisa and Pawlak, Joan and Saravolatz, Stephanie and Saravolatz, Louis D and Weinstein, Melvin P and LaVoie, Edmond J and Pilcha, Daniel S
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 08/2015, Volume 59, Issue 8, pp. 4845 - 4855
The clinical development of FtsZ-targeting benzamide compounds like PC190723 has been limited by poor drug-like and pharmacokinetic properties. Development of... 
ANTISTAPHYLOCOCCAL EFFICACY | ANTIBIOTICS | CYTOSKELETON | BACTERIAL-CELL DIVISION | RING | MRSA | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | PROTEIN FTSZ | INHIBITOR PC190723 | DAPTOMYCIN | INSIGHTS | Methicillin Resistance - drug effects | Benzamides - pharmacokinetics | Humans | Half-Life | Methicillin - pharmacology | Vancomycin - pharmacology | Linezolid - pharmacology | Cytoskeletal Proteins - metabolism | Benzamides - pharmacology | Staphylococcal Infections - drug therapy | Methicillin-Resistant Staphylococcus aureus - drug effects | Cells, Cultured | Rats | Daptomycin - pharmacology | Methicillin-Resistant Staphylococcus aureus - metabolism | Animals | Prodrugs - pharmacokinetics | Anti-Bacterial Agents - pharmacokinetics | Dogs | Bacterial Proteins - metabolism | Anti-Bacterial Agents - pharmacology | Mice | Mice, Inbred BALB C | Pyridines - pharmacology | Thiazoles - pharmacology | Microbial Sensitivity Tests - methods | Prodrugs - pharmacology | Index Medicus | Pharmacology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Inhibitory interaction potential of 22 antituberculosis drugs on organic anion and cation transporters of the SLC22A family
by Masud Parvez, M and Kaisar, Nazia and Shin, Ho Jung and Jung, Jin Ah and Shin, Jae-Gook
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 11/2016, Volume 60, Issue 11, pp. 6558 - 6567
Twenty-two currently marketed antituberculosis drugs were comprehensively evaluated for their inhibitory effect on organic anionic transporter (OAT)-and... 
IN-VITRO | PHARMACOKINETICS | ZIDOVUDINE | MEMBRANE | OCT2 | METHOTREXATE | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | OAT1 | ATORVASTATIN | PREDICTION | Octamer Transcription Factor-1 - antagonists & inhibitors | Organic Anion Transport Protein 1 - metabolism | Organic Anion Transporters, Sodium-Independent - antagonists & inhibitors | Humans | Levofloxacin - pharmacology | Organic Cation Transporter 2 | Pyrazinamide - pharmacology | Rifabutin - pharmacology | Organic Cation Transport Proteins - antagonists & inhibitors | Organic Anion Transporters, Sodium-Independent - metabolism | HEK293 Cells | Linezolid - pharmacology | Inhibitory Concentration 50 | Ion Transport - drug effects | 1-Methyl-4-phenylpyridinium - metabolism | Organic Anion Transport Protein 1 - antagonists & inhibitors | Organic Cation Transport Proteins - metabolism | Zidovudine - antagonists & inhibitors | Metformin - pharmacology | Antitubercular Agents - pharmacology | Ciprofloxacin - pharmacology | Zidovudine - pharmacology | Metformin - antagonists & inhibitors | Animals | Aminosalicylic Acid - pharmacology | Kinetics | Rifampin - pharmacology | Octamer Transcription Factor-1 - metabolism
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Effect of Pulmonary Surfactant on Antimicrobial Activity In Vitro
by R. Schwameis and Z. Erdogan-Yildirim and M. Manafi and M. A. Zeitlinger and S. Strommer and R. Sauermann
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 10/2013, Volume 57, Issue 10, pp. 5151 - 5154
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit... 
MICROBIOLOGY | PHARMACOLOGY & PHARMACY | Fluoroquinolones | Linezolid | Minocycline - pharmacology | Anti-Infective Agents - pharmacology | Minocycline - analogs & derivatives | Acetamides - pharmacology | Aza Compounds - pharmacology | Pulmonary Surfactants - pharmacology | Quinolines - pharmacology | Microbial Sensitivity Tests | Daptomycin - pharmacology | Animals | Carbapenems - pharmacology | Colistin - pharmacology | Oxazolidinones - pharmacology | Swine | Staphylococcus aureus - drug effects | Pharmacology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text In vitro activities of miltefosine and antibacterial agents from the macrolide, oxazolidinone, and pleuromutilin classes against pythium insidiosum and pythium aphanidermatum
by Loreto, Erico S and Tondolo, Juliana S. M and Oliveira, Daniele C and Santurio, Janio M and Alves, Sydney H
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 03/2018, Volume 62, Issue 3
We tested 29 isolates of Pythium insidiosum and one isolate of Pythium aphanidermatum to investigate their susceptibility to miltefosine and antibacterial... 
Oomycetes | Treatment | Susceptibility | Pythiosis | VORICONAZOLE | treatment | MINOCYCLINE | susceptibility | oomycetes | MICROBIOLOGY | AMPHOTERICIN-B | AZITHROMYCIN | MODEL | COMBINATION | TIGECYCLINE | CANDIDA-ALBICANS | PHARMACOLOGY & PHARMACY | pythiosis | Diterpenes - pharmacology | Oomycetes - drug effects | Humans | Bridged Bicyclo Compounds, Heterocyclic | Phosphorylcholine - analogs & derivatives | Josamycin - pharmacology | Azithromycin - pharmacology | Pythiosis - microbiology | Animals | Oxazolidinones - pharmacology | Phosphorylcholine - pharmacology | Linezolid - pharmacology | Macrolides - pharmacology | Anti-Bacterial Agents - pharmacology | Pythium - drug effects | Clarithromycin - pharmacology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Susceptibility of Clostridium difficile isolates of varying antimicrobial resistance phenotypes to SMT19969 and 11 comparators
by Freeman, Jane and Vernon, Jonathan and Vickers, Richard and Wilcox, Mark H
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 01/2016, Volume 60, Issue 1, pp. 689 - 692
We determined the in vitro activity of SMT19969 and 11 comparators, including metronidazole, vancomycin, and fidaxomicin, against 107 C. difficile isolates of... 
AGENT | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | IN-VITRO | INFECTION | FIDAXOMICIN | Humans | Clostridium difficile - genetics | Ceftriaxone - pharmacology | Clostridium difficile - isolation & purification | Metronidazole - pharmacology | Microbial Sensitivity Tests | Clostridium Infections - microbiology | Phenotype | Ribotyping | Drug Resistance, Multiple, Bacterial | Fluoroquinolones - pharmacology | Vancomycin - pharmacology | Linezolid - pharmacology | Benzimidazoles - pharmacology | Clostridium Infections - drug therapy | Anti-Bacterial Agents - pharmacology | Pyridines - pharmacology | Aminoglycosides - pharmacology | Clostridium difficile - drug effects
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Tuberculosis: clinical trials and new drug regimens
by Kwon, Yong-Soo and Jeong, Byeong-Ho and Koh, Won-Jung
Current Opinion in Pulmonary Medicine, ISSN 1070-5287, 05/2014, Volume 20, Issue 3, pp. 280 - 286
PURPOSE OF REVIEWRecent advances in the development of new drugs and regimens provide hope that well tolerated, effective, and shorter-duration treatments for... 
clinical trial | antitubercular agents | multidrug-resistant tuberculosis | tuberculosis | STERILIZING ACTIVITIES | INTENSIVE PHASE TREATMENT | MEROPENEM-CLAVULANATE | EARLY BACTERICIDAL ACTIVITY | TREATMENT OUTCOMES | ANTITUBERCULAR DRUG | KILL MYCOBACTERIUM-TUBERCULOSIS | IN-VITRO | RESPIRATORY SYSTEM | PULMONARY TUBERCULOSIS | Linezolid | Adamantane - pharmacology | Nitroimidazoles - pharmacology | Drug Administration Schedule | Humans | Antitubercular Agents - pharmacology | Acetamides - pharmacology | Male | Clinical Trials as Topic | Levofloxacin - pharmacology | Moxifloxacin | Diarylquinolines - pharmacology | Ethylenediamines - pharmacology | Oxazolidinones - pharmacology | Fluoroquinolones - pharmacology | Tuberculosis - drug therapy | Drug Design | Thiazines - pharmacology | Female | Oxazoles - pharmacology | Spiro Compounds - pharmacology | Adamantane - analogs & derivatives | Tuberculosis, Multidrug-Resistant - drug therapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text New insights into the in vitro susceptibility of Pythium insidiosum
by Loreto, Érico S and Tondolo, Juliana S. M and Pilotto, Maiara B and Alves, Sydney H and Santurioa, Janio M
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 12/2014, Volume 58, Issue 12, pp. 7534 - 7537
We have determined the in vitro activity of several antibacterial and antifungal drugs against Pythium insidiosum using broth microdilution (BMD), disk... 
HUMAN PYTHIOSIS | TERBINAFINE | VORICONAZOLE | CASPOFUNGIN | IBUPROFEN | INFECTIONS | FLUVASTATIN | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | ITRACONAZOLE | Antifungal Agents - pharmacology | Linezolid | Minocycline - pharmacology | Minocycline - analogs & derivatives | Acetamides - pharmacology | Pythium - growth & development | Mupirocin - pharmacology | Azithromycin - pharmacology | Microbial Sensitivity Tests | Oxazolidinones - pharmacology | Doxycycline - pharmacology | Anti-Bacterial Agents - pharmacology | Pythium - drug effects | Clarithromycin - pharmacology | Susceptibility
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Contribution of oxazolidinones to the efficacy of novel regimens containing bedaquiline and pretomanid in a mouse model of tuberculosis
by Tasneen, Rokeya and Betoudji, Fabrice and Tyagi, Sandeep and Li, Si-Yang and Williams, Kathy and Converse, Paul J and Dartois, Véronique and Yang, Tian and Mendel, Carl M and Mdluli, Khisimuzi E and Nuermberger, Eric L
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 01/2016, Volume 60, Issue 1, pp. 270 - 277
New regimens based on two or more novel agents are sought to shorten or simplify treatment of tuberculosis (TB). Pretomanid (PMD) is a nitroimidazole in phase... 
MYCOBACTERIUM-TUBERCULOSIS | PNU-100480 | MURINE MODEL | PHARMACOKINETICS | STERILIZING ACTIVITY | THIGH INFECTION MODEL | MULTIDRUG-RESISTANT TUBERCULOSIS | PULMONARY TUBERCULOSIS | PNEUMONIA MODEL | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | STAPHYLOCOCCUS-AUREUS | Lung - microbiology | Tuberculosis, Pulmonary - microbiology | Tuberculosis, Pulmonary - drug therapy | Diarylquinolines - pharmacology | Mycobacterium tuberculosis - drug effects | Pyrazinamide - pharmacology | Time Factors | Linezolid - pharmacology | Female | Disease Models, Animal | Nitroimidazoles - pharmacology | Drug Administration Schedule | Antitubercular Agents - pharmacology | Treatment Outcome | Bacterial Load | Drug Synergism | Organophosphates - pharmacology | Animals | Oxazolidinones - pharmacology | Lung - drug effects | Mice | Mice, Inbred BALB C | Oxazoles - pharmacology | Drug Resistance, Multiple, Bacterial - drug effects | Drug Combinations | Mycobacterium tuberculosis - growth & development
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Selection of resistance to clarithromycin in Mycobacterium abscessus subspecies
by Mougari, Faiza and Bouziane, Feriel and Crockett, Flora and Nessar, Rachid and Chau, Françoise and Veziris, Nicolas and Sapriel, Guillaume and Raskine, Laurent and Cambau, Emmanuelle
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 01/2017, Volume 61, Issue 1
Mycobacterium abscessus is an emerging pathogen against which clarithromycin is the main drug used. Clinical failures are commonly observed and were first... 
Resistant mutants | Clarithromycin | rrl | Mycobacterium abscessus | Antibiotic resistance | ARN23S | CAMPYLOBACTER-JEJUNI | resistant mutants | NONTUBERCULOUS MYCOBACTERIA | MICROBIOLOGY | clarithromycin | DRUG-RESISTANCE | RAPIDLY GROWING MYCOBACTERIA | STREPTOCOCCUS-PNEUMONIAE | antibiotic resistance | CYSTIC-FIBROSIS PATIENTS | INDUCIBLE RESISTANCE | PHARMACOLOGY & PHARMACY | MACROLIDE RESISTANCE | RIBOSOMAL MUTATIONS | MOLECULAR-MECHANISMS | Minocycline - pharmacology | Minocycline - analogs & derivatives | Ciprofloxacin - pharmacology | Amikacin - pharmacology | Mutation - genetics | Imipenem - pharmacology | Cefoxitin - pharmacology | Mycobacterium - genetics | Microbial Sensitivity Tests | Mycobacterium - drug effects | Linezolid - pharmacology | Anti-Bacterial Agents - pharmacology | Clarithromycin - pharmacology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Impact of High-Inoculum Staphylococcus aureus on the Activities of Nafcillin, Vancomycin, Linezolid, and Daptomycin, Alone and in Combination with Gentamicin, in an In Vitro Pharmacodynamic Model
by Kerry L. LaPlante and Michael J. Rybak
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 12/2004, Volume 48, Issue 12, pp. 4665 - 4672
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit... 
SIMULATED ENDOCARDIAL VEGETATIONS | EFFICACY | QUINUPRISTIN-DALFOPRISTIN | INVITRO | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | ANAEROBIC CONDITIONS | ANTIBIOTIC-TREATMENT | BACTERICIDAL ACTIVITIES | INFECTION MODEL | RESISTANT ENTEROCOCCUS-FAECIUM | BIOFILM FORMATION | Linezolid | Endocarditis, Bacterial - drug therapy | Area Under Curve | Drug Resistance, Bacterial | Half-Life | Acetamides - pharmacology | Drug Therapy, Combination - pharmacology | Microbial Sensitivity Tests | Daptomycin - pharmacology | Culture Media | Gentamicins - pharmacology | Oxazolidinones - pharmacology | Vancomycin - pharmacology | Endocarditis, Bacterial - microbiology | Anti-Bacterial Agents - pharmacology | Kinetics | Methicillin Resistance | Penicillins - pharmacology | Staphylococcus aureus - drug effects | Staphylococcus aureus - growth & development | Nafcillin - pharmacology | Clinical Therapeutics
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Susceptibility Profiles of Nocardia Isolates Based on Current Taxonomy
by Robert Schlaberg and Mark A. Fisher and Kimberley E. Hanson
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 02/2014, Volume 58, Issue 2, pp. 795 - 800
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit... 
BROTH MICRODILUTION | SPP | FLUCYTOSINE | ASTEROIDES | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | AMPHOTERICIN-B | SP NOV | EPIDEMIOLOGIC CUTOFF VALUES | Linezolid | Nocardia - classification | Species Specificity | Humans | Drug Resistance, Bacterial | Acetamides - pharmacology | Ceftriaxone - pharmacology | Phylogeny | Amikacin - pharmacology | Imipenem - pharmacology | Microbial Sensitivity Tests | Trimethoprim, Sulfamethoxazole Drug Combination - pharmacology | Oxazolidinones - pharmacology | Nocardia Infections - microbiology | Nocardia - drug effects | Nocardia - genetics | Anti-Bacterial Agents - pharmacology | Nocardia - isolation & purification | Nocardia Infections - drug therapy | Susceptibility
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05
by Steinkraus, Gregory and White, Roger and Friedrich, Lawrence
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 10/2007, Volume 60, Issue 4, pp. 788 - 794
Objectives To assess whether methicillin-resistant Staphylococcus aureus (MRSA) vancomycin MIC shifts (MIC creep) at a tertiary care institution occurred that... 
Linezolid | Susceptibility | Daptomycin | INFECTIOUS DISEASES | linezolid | susceptibility | THERAPY | EFFICACY | BACTEREMIA | HETERORESISTANCE | daptomycin | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | OUTCOMES | SERIOUS INFECTIONS | Staphylococcus aureus - isolation & purification | Humans | Oxacillin - pharmacology | Acetamides - pharmacology | Bacteremia - microbiology | Microbial Sensitivity Tests | Time Factors | Oxazolidinones - pharmacology | Vancomycin - pharmacology | Anti-Bacterial Agents - pharmacology | Staphylococcal Infections - microbiology | Methicillin Resistance | Staphylococcus aureus - drug effects | Staphylococcus infections | Chemotherapy | Pharmacology | Antibiotics | Drug resistance
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text Prevention of High-Level Daptomycin-Resistance Emergence In Vitro in Streptococcus mitis-oralis by Using Combination Antimicrobial Strategies
by Zapata, Brianne and Alvarez, Danya N and Farah, Sabrina and Garcia-de-la-Maria, Cristina and Miro, Jose M and Sakoulas, George and Bayer, Arnold S and Mishra, Nagendra N
Current Microbiology, ISSN 0343-8651, 8/2018, Volume 75, Issue 8, pp. 1062 - 1067
Among the viridans group streptococci, S. mitis-oralis strains are frequently resistant to multiple β-lactams and tolerant to vancomycin (VAN). This scenario... 
Life Sciences | Microbiology | Biotechnology | VANCOMYCIN | BACTEREMIA | SUSCEPTIBILITY | ENTEROCOCCUS-FAECALIS | MICROBIOLOGY | STAPHYLOCOCCUS-AUREUS | INFECTIVE ENDOCARDITIS | MODEL | CEFTAROLINE | VIRIDANS GROUP STREPTOCOCCI | PENICILLIN | Humans | Drug Resistance, Bacterial | Imipenem - pharmacology | Streptococcus oralis - drug effects | Microbial Sensitivity Tests | Organophosphates - pharmacology | Daptomycin - pharmacology | Trimethoprim, Sulfamethoxazole Drug Combination - pharmacology | Gentamicins - pharmacology | Linezolid - pharmacology | Anti-Bacterial Agents - pharmacology | Oxazoles - pharmacology | Streptococcus mitis - drug effects | Rifampin - pharmacology | Cephalosporins - pharmacology | Drug Combinations | Medicine, Experimental | Medical colleges | Medical research | Aminoglycosides | Usage | Rifampin | Linezolid | Level (quantity) | Gentamicin | Daptomycin | Trimethoprim | Exposure | Inosine monophosphate | Vancomycin | Sulfamethoxazole | Antibiotics | Emergence | In vivo methods and tests | Imipenem
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
17. Full Text In Vitro, In Vivo, and Clinical Studies of Tedizolid To Assess the Potential for Peripheral or Central Monoamine Oxidase Interactions
by S. Flanagan and K. Bartizal and S. L. Minassian and E. Fang and P. Prokocimer
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 07/2013, Volume 57, Issue 7, pp. 3060 - 3066
OA  Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley... 
PHOSPHATE | SEROTONIN TOXICITY | ANTIDEPRESSANTS | SKIN-STRUCTURE INFECTIONS | TYRAMINE | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | B INHIBITOR RASAGILINE | STAPHYLOCOCCUS-AUREUS | ANTIBACTERIAL AGENTS | MAO-B | HALLUCINOGENS | Linezolid | Organophosphates - metabolism | Pseudoephedrine - metabolism | Tetrazoles - pharmacology | Humans | Middle Aged | Male | Tetrazoles - metabolism | Young Adult | Adult | Female | Blood Pressure - drug effects | Oxazolidinones - metabolism | Tyramine - metabolism | Monoamine Oxidase Inhibitors - pharmacology | Oxazoles - metabolism | Serotonin Agents - metabolism | Organophosphates - pharmacology | Acetamides - metabolism | Animals | Serotonin Agents - pharmacology | Oxazolidinones - pharmacology | Serotonin - metabolism | Adolescent | Monoamine Oxidase Inhibitors - metabolism | Aged | Anti-Bacterial Agents - pharmacology | Mice | Oxazoles - pharmacology | Monoamine Oxidase - metabolism | Index Medicus | Clinical Therapeutics
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights